Today: Die gefährliche Schuldenwette der USA
Die USA finanzieren ihre Schulden zunehmend über kurzlaufende Schuldtitel. Für die Finanzmärkte ist das riskant. Und: Wie Moderna von einem Krebsimpfstoff profitieren könnte.
This week, global investors have been most concerned about uncertainty in bond markets. US Treasury bonds with a 30-year maturity reached their highest yield since 2007 at 5.34 percent. In response to this development, US Treasury Secretary Scott Bessent announced a doubling of the buyback volume for papers with maturities between ten and 30 years. This initially brought a sense of relief, but it does not address a structural problem - the way the United States finances its sovereign debt.
Antonia Mannweiler, US correspondent for Handelsblatt Today, explains why the underlying mechanism poses a significant risk to financial markets. The article also examines the dramatic rise in Moderna's stock price after the US biotech company announced a study success for a new cancer vaccine. The stock's gain reached 177 percent at one point on Wednesday. Markus Manns, senior portfolio manager at Union Investment, discusses in a podcast how justified investor euphoria is.
Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
